Rally #188-1-1910
Sekisui Diagnostics #MTRX-C19+FLU-B1
Metrix® COVID/Flu Molecular Test Bundle (1/KT)
Respiratory Test Bundle, Molecular NAAT (RT‑LAMP), COVID‑19/Flu A+B Detection, Anterior Nasal Swab, Machine-Read via Metrix® Reader (Gen 2), Includes 1 Reader + 50 Tests.
Features
- Includes 1 Metrix® Reader (Gen 2) and 50 molecular COVID/Flu A+B tests.
- Uses advanced RT‑LAMP technology for accurate molecular detection.
- Detects and differentiates COVID-19, Influenza A, and Influenza B.
- Automated machine-read results reduce user error.
- Simple anterior nasal swab collection for patient comfort.
- Fast results support quick and informed decisions.
- Compact, portable system perfect for point-of-care settings.
- Single-use sensor design ensures easy and efficient testing.
Important Note:
- For in vitro diagnostic use.
- Non-Returnable: Due to safety regulations, returns are not accepted for this item.
- All components other than the Metrix Reader (Gen 2) are single use and should be disposed of after use.
- Authorized for Use in Patient Care Settings with a CLIA Certificate of Waiver Under FDA EUA.
- For use under Emergency Use Authorization (EUA) only.
- For more information on this product's EUA, please go to the EUA section below.
Rally # | 188‑1‑1910 |
Manufacturer # | MTRX‑C19+FLU‑B1 |
Brand | Metrix® |
Manufacturer | Sekisui Diagnostics |
Country of Origin | Unknown |
Purchase Type | Bundle – Includes Reader + Test Kits |
For Use With | Metrix® COVID/Flu Test devices |
Number of Tests | 50 Tests total |
Analyzer Type | Handheld reusable electronic reader |
Multiplex Capability | Detects SARS-CoV-2, Influenza A, and Influenza B |
Readout Type | LED display, machine‑read results |
Sample Type | Anterior nasal swab |
Technology | RT‑LAMP (isothermal nucleic acid amplification) |
Storage Conditions | Room temperature, 15–30 °C (59–86 °F) |
Usage | Single-use test devices; reusable reader |
Time to Results | ~20 Minutes |
Warranty | 1-Year Limited Warranty (Metrix® Reader) |
Rally # | 188-1-1915 |
Manufacturer # | MTRX‑C19+FLU‑25PK |
Brand | Metrix® |
Manufacturer | Sekisui Diagnostics |
Country of Origin | Unknown |
Application | Respiratory Multiplex Test (COVID‑19, Influenza A & B) |
For Use With | Metrix® Reader (Gen 2) |
Number of Tests | 25 Tests/Kit |
Reading Type | Machine‑read via Metrix Reader |
Sample Type | Anterior nasal swab (self or adult-collected) |
Test Format | Single-use sensor device |
Technology | RT-LAMP (isothermal nucleic acid amplification) |
Multiplex Capability | Detects SARS‑CoV‑2, Flu A, Flu B |
Time to Results | 20 minutes |
Storage Conditions | Room Temperature, 15–30 °C (59–86 °F) |
Usage | Single Use Only |
Manufacturer # | MTRX‑RDR‑Gen2 |
Brand | Metrix® |
Manufacturer | Sekisui Diagnostics |
Application | Reusable Reader for Metrix® Molecular Tests |
Dimensions | 105 × 76 × 20 mm (4.13 × 3.0 × 0.79 in) |
Weight | 78–82 g (2.75 oz) |
Power Supply | USB‑C Power Adapter (5V DC, 3A) |
Readout Interface | LED multicolor indicators with printed labels |
Technology | RT‑LAMP nucleic acid amplification reader |
Sample Compatibility | Anterior nasal swab–based Metrix COVID/Flu tests |
Calibration | Not required (maintenance-free) |
Time to Results | ~20 Minute Results |
Storage Conditions | Room Temperature (15–30 °C / 59–86 °F) |
Warranty | 1-Year Limited Warranty |
Analyte | Positive Percent Agreement (PPA) | Negative Percent Agreement (NPA) | Limit of Detection (LOD) |
SARS-CoV-2 | 96% | 99% | 500 GE/Swab |
Flu A | 96% | 99% | 1000 GE/Swab |
Flu B | 95% | 99% | 2000 GE/Swab |
Configurations
Description | Quantity | Catalog Number |
Metrix Reader (Gen 2) | 1 Reader | MTRX-RDR-Gen2 |
Metrix COVID/Flu Test | 25 Tests | MTRX-C19+Flu-25PK |
Metrix COVID/Flu Molecular Test Bundle | 1 Reader + 50 Tests | MTRX-C19+FLU-B1 |
Package Contents
- Reusable handheld device for reading test results
- Power adapter for charging
- USB-C power cable
- Quick Start Guide
- 25 Single-use test devices per kit
- 25 Collectors
- 25 Caps
- 25 Sensors
- 25 Anterior nasal swabs for sample collection
- Quick reference instructions
Emergency Use Authorization
This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA;
This product has been authorized only for the detection and differentiation of nucleic acid from SARS-CoV-2, influenza A, and influenza B, not for any other viruses or pathogens; and,
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Additional information about this product’s authorization can be found on the FDA Website.
Documentation Links
Reimbursements Information
This product may be eligible for reimbursement depending on current laws, policies, and individual circumstances. Please note that Rally Inc. does not handle, manage or process any reimbursements. All reimbursement matters are handled directly between you and the product manufacturer. To determine your eligibility and request reimbursement, please follow the manufacturer's reimbursement guidelines and instructions.
You can find more information on reimbursement details for this product below:
MTRX-C19+Flu-25PK : 87636QW
MTRX-C19+FLU-B1 : 87636QW
Link: Sales Sheet.
Disclaimer:
Rally Inc. assumes no responsibility for the accuracy, completeness, or timeliness of the reimbursement information provided by the product manufacturer. Reimbursement policies are subject to change, and customers are encouraged to contact the product manufacturer directly for the most current information.
Manufacturer contact information for current product:
Sekisui Diagnostics:
https://sekisuidiagnostics.com/contact-us/.